Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2026-01-04 @ 8:01 PM
Study NCT ID:
NCT02085460
Status:
COMPLETED
Last Update Posted:
2021-10-18
First Post:
2014-03-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck Cancer
Sponsor:
Otsuka Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03
Start Date Type:
None
Primary Completion Date:
2015-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-08
Completion Date Type:
ACTUAL
First Submit Date:
2014-03-11
First Submit QC Date:
None
Study First Post Date:
2014-03-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-03-11
Results First Submit QC Date:
None
Results First Post Date:
2021-04-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-22
Last Update Post Date:
2021-10-18
Last Update Post Date Type:
ACTUAL